| MolName | (5Z)-3-(oxolan-2-ylmethyl)-5-[[4-oxo-2-(4-phenylpiperazin-1-yl)pyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one |
| MolecularFormula | C27H27N5O3S2 |
| Smiles | O=C(/C(/S1)=C/C2=C(N(CC3)CCN3c3ccccc3)N=C(C=CC=C3)N3C2=O)N(CC2OCCC2)C1=S |
| InChI | InChI=1S/C27H27N5O3S2/c33-25-21(17-22-26(34)32(27(36)37-22)18-20-9-6-16-35-20)24(28-23-10-4-5-11-31(23)25)30-14-12-29(13-15-30)19-7-2-1-3-8-19/h1-5,7-8,10-11,17,20H,6,9,12-16,18H2/t20-/m1/s1 |
| InChIK | HTZUZIAIABXDHM-HXUWFJFHSA-N |
| TotalMolweight | 533.675 |
| Molweight | 533.675 |
| MonoisotopicMass | 533.15553 |
| CLogP | 1.4047 |
| CLogS | -5.189 |
| H Acceptors | 8 |
| TotalSurfaceArea | 388.84 |
| Relative PSA | 0.2759 |
| PolarSurfaceArea | 126.08 |
| Druglikeness | 5.8138 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.48649 |
| Fragments | 1 |
| Non HAtoms | 37 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| StereoCenters | 1 |
| Rotatable Bond | 5 |
| Rings Closures | 6 |
| Small Rings | 6 |
| Aromatic Rings | 1 |
| Aromatic Atoms | 6 |
| Sp3Atoms | 12 |
| Symmetricatoms | 4 |
| Amides | 2 |
| Amines | 1 |
| Aromatic Amines | 1 |
| BasicNitrogens | 1 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (5Z)-3-(oxolan-2-ylmethyl)-5-[[4-oxo-2-(4-phenylpiperazin-1-yl)pyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one | 2 - (5Z)-3-(oxolan-2-ylmethyl)-5-[[4-oxo-2-(4-phenylpiperazin-1-yl)pyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one